clinical trial · NCT04958265
A Study Evaluating the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of Crovalimab in Pediatric Participants With Atypical Hemolytic Uremic Syndrome (aHUS)
Hoffmann-La Roche·phase3·active not recruiting·n = 41
Atypical Hemolytic Uremic SyndromeCrovalimab
brief summary
This study aims to evaluate the efficacy and safety of crovalimab in pediatric participants with aHUS.
started
Nov 17, 2021
primary completion
Jul 4, 2025
completion
May 19, 2029
last updated
Mar 27, 2026
official title
A Phase III, Multicenter, Single-Arm Study Evaluating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Crovalimab in Pediatric Patients With Atypical Hemolytic Uremic Syndrome (aHUS)
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol